Fate Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. 

CEO
Bahram Valamehr
CEOBahram Valamehr
Employees
181
Employees181
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
181
Employees181

FATE Key Statistics

Market cap
140.15M
Market cap140.15M
Price-Earnings ratio
-0.92
Price-Earnings ratio-0.92
Dividend yield
Dividend yield
Average volume
1.99M
Average volume1.99M
High today
$1.28
High today$1.28
Low today
$1.20
Low today$1.20
Open price
$1.25
Open price$1.25
Volume
1.36M
Volume1.36M
52 Week high
$1.94
52 Week high$1.94
52 Week low
$0.6611
52 Week low$0.6611

Stock Snapshot

Fate Therapeutics(FATE) stock is priced at $1.21, giving the company a market capitalization of 140.15M. It carries a P/E multiple of -0.92.

During the trading session on 2026-01-24, Fate Therapeutics(FATE) shares reached a daily high of $1.28 and a low of $1.20. At a current price of $1.21, the stock is +0.8% higher than the low and still -5.5% under the high.

Trading volume for Fate Therapeutics(FATE) stock has reached 1.36M, versus its average volume of 1.99M.

Over the past 52 weeks, Fate Therapeutics(FATE) stock has traded between a high of $1.94 and a low of $0.66.

Over the past 52 weeks, Fate Therapeutics(FATE) stock has traded between a high of $1.94 and a low of $0.66.

FATE News

Simply Wall St 7d
Great week for Fate Therapeutics, Inc. institutional investors after losing 6.3% over the previous year

Advertisement Key Insights Significantly high institutional ownership implies Fate Therapeutics' stock price is sensitive to their trading actions The top 10...

Great week for Fate Therapeutics, Inc. institutional investors after losing 6.3% over the previous year

Analyst ratings

50%

of 12 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own FATE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.